2017 THRIVE Grant Award Winners


HESI THRIVE Research Study: Evaluating co-therapies that may reduce skin and metabolic side effects of glucocorticoids in patients with blood cancers (e.g., leukemia,
lymphoma, and myeloma)

  • Irina Budunova, MD, PhD
  • Northwestern University, Feinberg School of Medicine

HESI THRIVE Research Study: Defining the genetic profile of patients that experience adverse responses to immunotherapy to help inform future treatment selection

  • Maria Suarez-Almazor, MD, PhD
  • MD Anderson Cancer Center

HESI THRIVE Research Study: Developing a nerve function test that can characterize breast cancer patients most likely to experience serious nerve injury from breast cancer treatment

  • Barbara Ehrlich, PhD
  • Yale University

HESI THRIVE Research Study: Evaluating novel mechanisms of chronic heart damage with cardiac MRI in patients who have received anthracyclines

  • Jennifer Jordan, PhD
  • Wake Forest University School of Medicine

By providing researchers with both seed funding and access to critical networks, THRIVE will enhance the visibility of the patient need, the value of the research, and the reasons that larger funding entities might elect to incorporate these research streams into future funding priorities. Click here to learn more about grant guidelines, the application process, and selection process.